Mirae Asset Global Investments Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,708 shares of ARWR stock, worth $74,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,708
Previous 327,782
98.87%
Holding current value
$74,197
Previous $9.37 Million
98.98%
% of portfolio
0.0%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
92.3MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$314 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$244 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$178 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$117 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$82.8 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.12B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...